VTRS

#3193
Viatris Inc. - Common Stock
0.1 6 USD
-98.99%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.16
0.16
Range Annuel
0.16
17.53
Changement quotidien
-98.99%
Changement Mensuel
-98.92%
Evolution sur 6 mois
-98.47%
Changement Annuel
-98.43%
Clôture Précédente
16.1 1
Open
0.1 6
Low
0.1 6
High
0.1 6
Volume
438
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 189.36 M
  • Employee 30 K
  • Founded 2020
  • CEO Scott A. Smith
  • Website www.viatris.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y4RQNH4
  • Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-45.03
ratio cours/chiffre d'affaires
—
Dividende par action
0.12
Rendement du dividende (%)
3.55

Viatris Inc. - Common Stock

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

Nouvelles